{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:06:11Z","timestamp":1794002771764,"version":"4.8.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Chinese High Tech Research and Development (863) Program","award":["2011AA020104"],"award-info":[{"award-number":["2011AA020104"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acute-on-chronic liver failure (ACLF) is a severe, life-threatening complication, and new and efficient therapeutic strategies for liver failure are urgently needed. Mesenchymal stem cell (MSC) transfusions have been shown to reverse fulminant hepatic failure in mice and to improve liver function in patients with end-stage liver diseases. We assessed the safety and initial efficacy of umbilical cord-derived MSC (UC-MSC) transfusions for ACLF patients associated with hepatitis B virus (HBV) infection. A total of 43 ACLF patients were enrolled for this open-labeled and controlled study; 24 patients were treated with UC-MSCs, and 19 patients were treated with saline as controls. UC-MSC therapy was given three times at 4-week intervals. The liver function, adverse events, and survival rates were evaluated during the 48-week or 72-week follow-up period. No significant side effects were observed during the trial. The UC-MSC transfusions significantly increased the survival rates in ACLF patients; reduced the model for end-stage liver disease scores; increased serum albumin, cholinesterase, and prothrombin activity; and increased platelet counts. Serum total bilirubin and alanine aminotransferase levels were significantly decreased after the UC-MSC transfusions. UC-MSC transfusions are safe in the clinic and may serve as a novel therapeutic approach for HBV-associated ACLF patients.<\/jats:p>","DOI":"10.5966\/sctm.2012-0034","type":"journal-article","created":{"date-parts":[[2012,10,12]],"date-time":"2012-10-12T00:24:00Z","timestamp":1350001440000},"page":"725-731","source":"Crossref","is-referenced-by-count":321,"title":["Human Mesenchymal Stem Cell Transfusion Is Safe and Improves Liver Function in Acute-on-Chronic Liver Failure Patients"],"prefix":"10.1093","volume":"1","author":[{"given":"Ming","family":"Shi","sequence":"first","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"},{"name":"Research Center for Liver Transplantation, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Xu","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Lin","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Fu","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengsheng","family":"Zou","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Shi","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Chen","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa","family":"Lv","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"He","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Geng","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jin","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwen","family":"Liu","sequence":"additional","affiliation":[{"name":"Research Center for Liver Transplantation, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Research Center for Biological Therapy, Institute of Translational Hepatology, Beijing 302 Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,10,11]]},"reference":[{"key":"2021122705561100700_ref1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2008-1040593","article-title":"Fulminant and subfulminant liver failure: Definitions and causes","volume":"6","author":"Bernuau","year":"1986","journal-title":"Semin Liver Dis"},{"key":"2021122705561100700_ref2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJM199608293350904","article-title":"Hepatitis C virus-associated fulminant hepatic failure","volume":"335","author":"Farci","year":"1996","journal-title":"N Engl J Med"},{"key":"2021122705561100700_ref3","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"35","author":"Navarro","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122705561100700_ref4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol Int"},{"key":"2021122705561100700_ref5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"2021122705561100700_ref6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.20469","article-title":"In vitro hepatic differentiation of human mesenchymal stem cells","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatology"},{"key":"2021122705561100700_ref7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2021122705561100700_ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04327.x","article-title":"Immunomodulatory properties and therapeutic application of mesenchymal stem cells","volume":"164","author":"Shi","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"2021122705561100700_ref9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","article-title":"Mesenchymal stem cells: Mechanisms of inflammation","volume":"6","author":"Singer","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"2021122705561100700_ref10","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"2021122705561100700_ref11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/CBI20090386","article-title":"Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression","volume":"34","author":"Rabani","year":"2010","journal-title":"Cell Biol Int"},{"key":"2021122705561100700_ref12","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.lfs.2009.08.003","article-title":"Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis","volume":"85","author":"Chang","year":"2009","journal-title":"Life Sci"},{"key":"2021122705561100700_ref13","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","article-title":"Stem cell therapy for liver disease: Parameters governing the success of using bone marrow mesenchymal stem cells","volume":"134","author":"Kuo","year":"2008","journal-title":"Gastroenterology"},{"key":"2021122705561100700_ref14","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/hep.22236","article-title":"Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo","volume":"47","author":"van Poll","year":"2008","journal-title":"Hepatology"},{"key":"2021122705561100700_ref15","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1634\/stemcells.2005-0542","article-title":"Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy","volume":"24","author":"Terai","year":"2006","journal-title":"Stem Cells"},{"key":"2021122705561100700_ref16","first-page":"459","article-title":"Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis","volume":"10","author":"Mohamadnejad","year":"2007","journal-title":"Arch Iran Med"},{"key":"2021122705561100700_ref17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","article-title":"Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: A phase I-II clinical trial","volume":"21","author":"Kharaziha","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"suppl 2","key":"2021122705561100700_ref18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","article-title":"Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients","volume":"27","author":"Zhang","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"2021122705561100700_ref19","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.24434","article-title":"Autologous bone mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes","volume":"54","author":"Peng","year":"2011","journal-title":"Hepatology"},{"key":"2021122705561100700_ref20","first-page":"1017","article-title":"Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials","volume":"91","author":"Lu","year":"2006","journal-title":"Haematologica"},{"key":"2021122705561100700_ref21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte-colony stimulating factor mobilizes CD34+ cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"key":"2021122705561100700_ref22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s10620-009-0733-4","article-title":"deficient proliferation of bone marrow-derived mesenchymal stem cells in patients with chronic hepatitis B viral infections and cirrhosis of the liver","volume":"55","author":"Zhong","year":"2010","journal-title":"Dig Dis Sci"},{"key":"2021122705561100700_ref23","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1478-3231.2009.02031.x","article-title":"Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model","volume":"29","author":"Jung","year":"2009","journal-title":"Liver Int"},{"key":"2021122705561100700_ref24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/lt.21715","article-title":"The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis","volume":"15","author":"Tsai","year":"2009","journal-title":"Liver Transpl"},{"key":"2021122705561100700_ref25","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.bbrc.2005.03.086","article-title":"In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells","volume":"330","author":"Hong","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"2021122705561100700_ref26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gut.2005.090050","article-title":"Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers","volume":"56","author":"Aurich","year":"2007","journal-title":"Gut"},{"key":"2021122705561100700_ref27","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/scd.2009.0254","article-title":"Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats","volume":"19","author":"Yu","year":"2010","journal-title":"Stem Cells Dev"},{"key":"2021122705561100700_ref28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2005-02-0572","article-title":"Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion","volume":"106","author":"Sato","year":"2005","journal-title":"Blood"},{"key":"2021122705561100700_ref29","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bbmt.2007.08.048","article-title":"Umbilical cord mesenchymal stem cells: Adjuvants for human cell transplantation","volume":"13","author":"Friedman","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"2021122705561100700_ref30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/scd.2007.0175","article-title":"In vitro secreting profile of human mesenchymal stem cells","volume":"17","author":"Schink\u00f6the","year":"2008","journal-title":"Stem Cells Dev"},{"key":"2021122705561100700_ref31","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcb.23395","article-title":"Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo","volume":"113","author":"Fong","year":"2012","journal-title":"J Cell Biochem"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2012-0034","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5966%2Fsctm.2012-0034","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/1\/10\/725\/41882319\/stcltm_1_10_725.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/1\/10\/725\/41882319\/stcltm_1_10_725.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:46:40Z","timestamp":1642560400000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/1\/10\/725-731\/6385503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,1]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2012,10,11]]},"published-print":{"date-parts":[[2012,10,1]]}},"URL":"https:\/\/doi.org\/10.5966\/sctm.2012-0034","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,10,1]]},"published":{"date-parts":[[2012,10,1]]}}}